CD24+ LCSCs display enhanced levels of inducible nitric oxide synthase (iNOS), which triggers the Notch1 signaling pathway in a manner dependent on cGMP/PKG-mediated activation of TACE and upregulation of iRhom-2, further promoting self-renewal and tumor growth properties [52]. The gene discussed is NOS2; the disease is neoplasm.